凝血酶原基因rs5896位点C＞T多态性与肾结石的 相关性

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1515 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：探讨凝血酶原基因rs5896位点C＞T多态性与浙南地区人群肾结石的相关性。方法：采用PCR-RFLP和测序技术分析102例肾结石患者（病例组）和年龄相匹配的95例健康人群（对照组）凝血酶原基因rs5896位点，比较此位点2组间基因型频率和等位基因频率差异。结果：凝血酶原基因rs5896位点CC、CT和TT基因型频率在病例组为13.7%、50.9%和35.4%，对照组为24.2%、51.6%和24.2%，2组比较差异有统计学意义（P=0.028）；等位基因C、T频率在病例组和对照组分别为39.2%、60.8%和50.0%、50.0%，差异有统计学意义（P=0.031）。结论：凝血酶原基因rs5896位点多态性与浙南地区人群患肾结石具有关联性，rs5896位点C＞T变异可能是肾结石的易感因素。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	季慧娟
	陈陶
	江明华
	王大文
	王怡君
	胡云良

关键词 ：多态性, 凝血酶原基因, 肾结石

Abstract：Objective: To investigate the correlation between prothrombin rs5896 C>T genetic polymorphism and kidney stone in the southern population of Zhejiang. Methods: Prothrombin gene polymorphism rs5896 was investigated in 102 patients with renal stone formation and 95 age-matched healthy volunteers without history of renal stone formation, using polymerase chain reaction-restriction fragment polymorphism (PCR-RFLP) and sequencing. The frequences of genetype and allele gene in the case and control were analyzed. Results: The frequencies of CC, CT, TT were 13.7%, 50.9%, 35.4% and 24.2%, 51.6%, 24.2% in kidney stone patients and healthy controls respectively. The difference between case and control was slight significance (P=0.028). The frequencies of C and T were 39.2%, 60.8% and 50.0%, 50.0% in kidney stone patients and heathy control. There was a different significance (P=0.031). Conclusion: It suggests that the rs5896 polymorphism of prothrombin gene is associated with the kidney stone in the southern population of Zhejiang, and it is possible that rs5896 C>T acts as a risk factor for the development of renal stone disease.

Key words： polymorphism prothrombin gene kidney stone

收稿日期: 2015-10-26

基金资助:高等学校博士学科点专项科研基金资助项目（2012 3321120002）；浙江省教育厅科研基金资助项目（Y201223619）。

通讯作者: 胡云良，教授，Email：hyl@wmu.edu.cn。

作者简介: 季慧娟（1989-），女，江西抚州人，硕士生。

链接本文:

https://xb.wmu.edu.cn/CN/ 或 https://xb.wmu.edu.cn/CN/Y2016/V46/I4/241

[1] 叶章群. 泌尿系结石研究现况与展望[J]. 中华实验外科杂志, 2005, 22(3): 261-262.
[2] 赵益华, 蒋旭敏, 黄伟, 等. B超引导“改良一步法”建立标准通道在经皮肾镜碎石术中的应用[J]. 温州医科大学学报, 2014, 44(12): 913-916.
[3] VEZZOLI G, TERRANEGRA A, ARCIDIACONO T, et al.Genetics and calcium nephrolithiasis[J]. Kidney Int, 2011,80: 587-593.
[4] GROVER P K, MORITZ R L, SIMPSON R J, et al. Inhibition of growth and aggregation of calcium oxalate crystals in vitro—a comparison of four human proteins[J]. Eur J Biochem, 1998, 253: 637-644.
[5] RUNGROJ N, SRITIPPAYAWAN S, THONGNOPPAKHUN W, et al. Prothrombin haplotype associated with kidney stone disease in Northeastern Thai patients[J]. Urology, 2011, 77: 249. e17-23.
[6] DOYLE I R, RYALL R L, MARSHALL V R. Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon[J]. Clin Chem, 1991, 37: 1589-1594.
[7] RYALL R L, GROVER P K, STAPLETON A M, et al. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro[J]. Clin Sci (Lond), 1995, 89: 533-541.
[8] ATKINSON R A, WILLIAMS R J. Solution structure of the kringle 4 domain from human plasminogen by 1H nuclear magnetic resonance spectroscopy and distance geometry[J]. J Mol Biol, 1990, 212: 541-552.
[9] POZZI N, CHEN Z, PELC L A, et al. The linker connecting the two kringles plays a key role in prothrombin activation [J]. Proc Natl Acad Sci U S A, 2014, 111: 7630-7635.
[10] RUNGROJ N, SUDTACHAT N, NETTUWAKUL C, et al.Association between human prothrombin variant (T165M)and kidney stone disease[J]. PLoS One, 2012, 7: e45533.
[11] WEBBER D, RODGERS A L, STURROCK E D. Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth[J]. Urol Res, 2007, 35: 277-285.
[12] WEBBER D, RADCLIFFE C M, ROYLE L, et al. Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation[J]. FEBS J, 2006, 273: 3024-3037.